Skip to Main Content

Paper Details

Phase I Trial of Dabrafenib and Pazopanib in <i>BRAF</i> Mutated Advanced Malignancies.
JCO Precis Oncol
1
2018
Author NameAffiliation
Susan GeyerOhio State University Medical Center, Stanford University, University of Texas MD Anderson Cancer Center, University of South Florida
  • 1 - 1

Datasets